Company Filing History:
Years Active: 2013-2023
Title: Yi-Sheng Shih: Innovator in Cancer and Infectious Disease Treatment
Introduction
Yi-Sheng Shih is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of malignant diseases and infectious diseases. With a total of four patents to his name, his work focuses on innovative therapeutic approaches that enhance immune responses.
Latest Patents
One of Yi-Sheng Shih's latest patents is titled "Combination therapy for malignant diseases." This invention presents a new method for treating malignant diseases by administering a traditional anti-cancer therapy alongside a DNA or protein vaccine that includes CTLA-4 and PD-1, or CTLA-4 and PD-L1. Another notable patent is "Method for enhancing immune response in the treatment of infectious and malignant diseases." This invention introduces new DNA and protein vaccines aimed at improving immune responses against both infectious and malignant diseases.
Career Highlights
Yi-Sheng Shih is affiliated with Taipei Veterans General Hospital, where he conducts his research and develops his innovative therapies. His work has garnered attention for its potential to revolutionize treatment protocols in oncology and infectious disease management.
Collaborations
He has collaborated with notable colleagues, including Keng-Li Lan and Keng-Hsin Lan, to further advance his research and innovations in the medical field.
Conclusion
Yi-Sheng Shih's contributions to medical science through his patents and research are paving the way for new treatment methodologies. His innovative approaches hold promise for improving patient outcomes in the fight against cancer and infectious diseases.